Invivac Injektionsvätska, suspension

Country: Շվեդիա

language: շվեդերեն

source: Läkemedelsverket (Medical Products Agency)

active_ingredient:

influensavirus A/California/7/2004 (H3N2)-liknande stam (A/New York/55/2004 (NYMC X-157)), ytantigen, inaktiverat; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat; influensavirus B/Shanghai/361/2002 - liknande stam (B/Jiangsu/10/2003), ytantigen, inaktiverat

MAH:

Abbott Biologicals B.V.

ATC_code:

J07BB02

INN:

the influenza virus A/California/7/2004 (H3N2)-like strain (A/New York/55/2004 (NYMC X-157)), surface antigen, inactivated; influenza virus (A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 (IVR-116)), surface antigen, inactivated; influenza virus B/Shanghai/361/2002 - like strain (B/Jiangsu/10/2003), a surface antigen, inactivated

pharmaceutical_form:

Injektionsvätska, suspension

composition:

influensavirus A/California/7/2004 (H3N2)-liknande stam (A/New York/55/2004 (NYMC X-157)), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus B/Shanghai/361/2002 - liknande stam (B/Jiangsu/10/2003), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat 15 mikrog Aktiv substans

prescription_type:

Receptbelagt

therapeutic_area:

spjälkat virus eller ytantigen

authorization_status:

Avregistrerad

authorization_date:

2004-10-08